1004-51-9

Usage

Uses

Used in Pharmaceutical Industry:
2-azaspirononan-1-one is used as a potential psychoactive drug for its anxiolytic and sedative effects, making it a candidate for the treatment of anxiety and sleep disorders. Its ability to modulate mood and promote relaxation positions it as a potential therapeutic agent in the management of stress-related conditions.
Used in Research and Development:
In the scientific community, 2-AS-1-one serves as a subject of investigation for understanding the mechanisms of action of psychoactive compounds. Its unique structure and effects on the central nervous system provide valuable insights into the development of novel therapeutics for neurological and psychiatric disorders.

Upstream product

• 4630-80-2 methyl cyclopentane carboxylate 
• 224561-34-6 3,3-diallylpyrrolidin-2-one 
• 1319716-35-2 tert-butyl 3,3-diallyl-2-oxopyrrolidine-1-carboxylate 
• 1319716-36-3 tert-butyl 1-oxo-2-azaspiro[4.4]nonan-7-ene-2-carboxylate 
• 175698-01-8 methyl 1-(cyanomethyl)cyclopentanecarboxylate 

Relevant academic research and scientific papers

SSAO INHIBITORS AND USE THEREOF

Provided are a compound of formula (I') or (I), a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of formula (I') or (I), and a method of treating or preventing a disease in which SSAO plays a role.

HIGHLY ACTIVE CSF1R INHIBITOR COMPOUND

ABSTRACT The present invention relates to a CSF1R inhibitor, and in particular to a highly active CSF1R inhibitor compound having the structure of formula (I). Said compound of the present invention has high inhibitory activity on CSF1R.

N-(AZAARYL)CYCLOLACTAM-1-CARBOXAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF

An N-(azaaryl)cyclolactam-1-carboxamide derivative having a structure of formula (I), a preparation method therefor, and a use thereof are disclosed in the application. Each substituent are defined in the specification and claims. The series of compounds of the application can be widely applied in the preparation of drugs for treating cancer, tumor, autoimmune disease, metabolic disease or metastatic disease, particularly for treating ovarian cancer, pancreatic cancer, prostate cancer, breast cancer, cervical cancer, glioblastoma, multiple myeloma, metabolic disease, neurodegenerative disease, primary tumor site metastasis or osseous metastasis cancer, and are expected to be developed into a new generation of CSF-1R inhibitor drugs.

3,3-Dialkyl- and 3-alkyl-3-benzyl-substituted 2-pyrrolidinones: A new class of anticonvulsant agents

A series of 3,3-dialkyl- and 3-alkyl-3-benzyl-substituted 2- pyrrolidinones (lactams) have been prepared and evaluated for their anticonvulsant activities. In the pentylenetetrazole mouse seizure model, 3,3-diethyl lactam 7c and 3-benzyl-3-ethyl lactam 7j